Immune and molecular determinants of response to neoadjuvant chemotherapy in inflammatory breast cancer.

被引：1
|
作者：
Reddy, Sangeetha Meda
Wargo, Jennifer Ann
Reuben, Alexandre
Tetzlaff, Michael T.
Roszik, Asori
Reuben, James M.
Woodward, Wendy A.
Ueno, Naoto T.
Krishnamurthy, Savitri
Mittendorf, Elizabeth Ann
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11501
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Changes in thymidine phosphorylase expression in response to neoadjuvant chemotherapy for primary breast cancer.
    Puglisi, F.
    Mansutti, M.
    Minisini, A.
    Russo, S.
    Cardellino, G.
    Andreetta, C.
    Rijavec, E.
    Pizzolitto, S.
    Pandolfi, M.
    Di Loreto, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 41S - 41S
  • [22] Demographic Determinants of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
    Anderson, Lisa
    Daniele, Karla
    Hayes, Madison
    Dancel, Canice Lei
    Dhanasekara, Samudani
    Rahman, Rakhshanda
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S383 - S384
  • [23] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [24] Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.
    Zdenkowski, Nicholas
    D'Silva, Shefi Mary
    Lawson, Kenny
    Reeves, Penny
    Boyle, Frances M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Molecular subtypes as a predictor of response to neoadjuvant chemotherapy in breast cancer patients
    Shanmugam, Subbiah
    Govindasamy, Gopu
    Senthilkumar, P.
    Muniasamy, P.
    INDIAN JOURNAL OF CANCER, 2017, 54 (04) : 652 - 657
  • [26] Response to neoadjuvant chemotherapy in breast cancer according to molecular profile analysis
    Cardona-Huerta, S.
    Santuario-Facio, S. K.
    Ortiz-Lopez, R.
    Perez-Paramo, Y. X.
    Rojas-Martinez, A.
    Trevino-Alvarado, V. M.
    Munoz-Maldonado, G. E.
    Barbosa-Quintana, O.
    Padilla-Rivas, G.
    Barbosa-Quintana, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S207 - S208
  • [27] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
  • [28] Array CGH analysisin neoadjuvant chemotherapy for breast cancer.
    Kim, JY
    Kwak, H
    Choi, KU
    Chung, J
    Bae, YT
    Lee, MK
    Kim, HW
    Park, DY
    Lee, CH
    Huh, KY
    Sol, MY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 74S - 74S
  • [29] Assessment of response and correlation study of several markers with response to neoadjuvant chemotherapy in patients with breast cancer.
    Zhang, B.
    Zhang, Q.
    Zhao, L.
    Long, F.
    Li, S.
    Jiang, D-q
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S153 - S153
  • [30] Correlation between miRNA and gene expression profiles and response to neoadjuvant chemotherapy in patients with locally advanced and inflammatory breast cancer.
    Somlo, G.
    Li, S. M.
    Wu, X.
    Lau, S.
    Frankel, P. H.
    Kruper, L.
    Gao, H.
    Sun, G.
    Yim, J. H.
    Hurria, A.
    Mortimer, J. E.
    De Snoo, F.
    Paz, I. B.
    Rossi, J.
    Wang, E.
    Roepman, P.
    Yen, Y.
    van't Veer, L.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345